Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients
Clinical trial NCT01568866 · COMPLETED
Trial details
- NCT number
- NCT01568866
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-20
- Primary completion
- 2014-11-10
- Enrollment
- 929
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.